Sinew Pharma Inc. (TPEX:6634)
53.50
+1.80 (3.48%)
Sep 8, 2026, 1:14 PM CST
Sinew Pharma Market Cap
Sinew Pharma has a market cap or net worth of 3.81 billion as of September 8, 2026. Its market cap has increased by 13.42% in one year.
Market Cap
3.81B
Enterprise Value
2.83B
Revenue
47.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
53.50
ChartMarket Cap Chart
Since June 29, 2017, Sinew Pharma's market cap has increased from 1.90B to 3.81B, an increase of 100.64%. That is a compound annual growth rate of 7.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 3.81B | 36.60% |
| Dec 31, 2025 | 2.79B | -17.68% |
| Dec 31, 2024 | 3.39B | -29.30% |
| Dec 29, 2023 | 4.80B | -34.51% |
| Dec 30, 2022 | 7.33B | 29.47% |
| Dec 30, 2021 | 5.66B | 19.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmosa Biopharm | 4.28B |
| Great Novel Therapeutics Biotech & Medicals | 3.93B |
| Formosa Pharmaceuticals | 3.72B |
| BioGend Therapeutics | 3.59B |
| SYN-TECH Chem. & Pharm. | 3.35B |
| OBI Pharma | 3.30B |
| Apex Biotechnology | 3.23B |
| BRIM Biotechnology | 3.21B |